Zydus Lifesciences posted a 31% rise in consolidated net profit to Rs 1,420 crore for Q1 FY25, up from Rs 1,087 crore last year. Revenue grew 20.9% to Rs 6,207 crore. US formulation sales rose 26%, and India sales increased 15%. The company’s strong performance reflects robust growth across markets.
Zydus Lifesciences Reports 31% Profit Increase to Rs 1,420 Crore
